Search

This article discusses a clinical trial, NCT06444282, that focuses on measuring the health outcomes of using an Emergency Care Action Plan (ECAP) for infants discharged from the Neonatal Intensive Care Unit (NICU). The ECAP is a tool designed to assist providers in treating infants with complex medical needs during emergencies. The trial will assess the challenges and feasibility of implementing the ECAP, as well as gather perspectives from providers and caregivers on its use. Participants will be randomly assigned to receive either an ECAP or standard care, and caregivers will complete surveys during a one-year feasibility trial period. The study aims to recruit 50 participants and is expected to be completed by August 2028. [Extracted from the article]

The article reports on a study that examined the effectiveness of probiotics in treatment of acute gastroenteritis in young children. Participants were children aged from three months to four years. Analysis of stool samples showed that 45.6 percent were positive for viruses and 15.2 percent were positive for bacteria that are probable or possible pathogens. The Vesikari Scoring System scale was used to examine the severity of gastroenteritis.

I am Ross Pelton, and I 'brand' myself as The Natural Pharmacist. I am writing to express my outrage and disappointment at an article titled 'The Probiotic Conundrum' (1) that [...]

Bedside ultrasonography is a core component of the practice of emergency medicine, and its use in the pediatric emergency setting has been growing. As a first-line imaging tool, it is [...]

1) Most of the infants born in the northern half of the US are at risk for rickets, especially if they are breast-fed. A) True B) False True. Dr. Joyce [...]

Of 973 preschool-aged children with acute gastroenteritis who visited 1 of 10 geographically diverse pediatric emergency departments (EDs), those who received a 5-day course of Lactobacillus rhamnosus GG, a commonly [...]